
Trump's 90 Days In Office: Another 25% S&P Crash Ahead?
22 February 2022, Hamburg: Stock prices of the S&P500 are shown on a smartphone against a red ... More background. Photo: Daniel Reinhardt/dpa (Photo by Daniel Reinhardt/picture alliance via Getty Images)
Have you been keeping an eye on your portfolio lately? Things have become quite interesting since January, and not in the way most investors would have hoped. In the roughly three months since Trump moved back into the White House, the financial markets have already taken quite a beating. Given the current trajectory, the markets could still experience another 25% decline.
Remember how the markets were riding high in January? Well, that party didn't last long. The S&P 500 has tumbled around 15% from its peak of over 6,140 to under 5,300 now. If you're heavy in tech stocks, we feel for you – the Nasdaq has taken an even bigger hit, down a whopping 20% from its highs.
And crypto enthusiasts? Bitcoin has corrected about 20% too. Meanwhile, 10-year government bond yields have fallen from 4.8% in January to 4.3% now, which typically signals investors fleeing to safer options.
Speaking of safe havens, gold has been shining bright – up roughly 25% so far this year. Classic flight to safety, right?
So what got us here? It all kicked off when the new administration started imposing those tariffs on trading partners. Remember those campaign promises about getting tough on trade? Well, they're becoming reality, and the trade war with China has escalated significantly.
Let's break this down in simple terms. When you slap higher tariffs on imports, you're basically taking cheaper goods out of the market. What happens next? Prices go up. That's just basic economics.
And rising prices could mean inflation spikes again. If that happens, the Fed might have to put those interest rate cuts we've all been hoping for on hold. Tricky situation, right?
But here's the real worry – economic growth slowing down, or worse, sliding into a recession. And if you think the market damage in Trump's first three months is bad, just wait until recession fears really take hold.
Let's get real about what markets do during economic stress. The S&P 500 has a track record of serious crashes:
During the dot-com bubble, it plunged 47%. The Great Financial Crisis? Even worse – down 55%. The COVID crash knocked it down 34%. Even the 2022 drawdown saw a 20% drop.
Those aren't small numbers. They represent trillions in market value vanishing.
Here's where things get really interesting. We're already down 15% on the S&P 500, but if we use those previous market crashes as our guide, we could be in for a much steeper decline.
Consider this: we're currently sitting at about a 15% drawdown from the peak. But the average of those four major market crashes we mentioned earlier is about 39%. That suggests we could potentially see another 24% decline from current levels if a full-blown recession materializes.
In real numbers, that would take the S&P 500 down from its current level around 5,300 to approximately 4,030 – erasing nearly two years of gains.
What's particularly concerning is that we've already seen this 15% decline without an official recession. Historically, the biggest market drops come when economic reality catches up with market sentiment.
So what's your move? Whatever you do, buckle up – if history is any guide, we might be in for a much bumpier ride than what we've seen so far. Surely, you can talk to professional financial advisors. Trefis works with Empirical Asset Management – a Boston area wealth manager, whose asset allocation strategies yielded positive returns even during the 2008/2009 timeframe, when the S&P lost more than 40%.
Empirical has incorporated the Trefis HQ Portfolio in its asset allocation framework to provide clients better returns with less risk versus the benchmark index; less of a roller-coaster ride, as evident in HQ Portfolio performance metrics.
While investors have their fingers crossed for a soft landing by the U.S. economy, how bad can things get if there is another recession? See the last six market crashes compared.
Invest with Trefis
Market Beating Portfolios | Rules-Based Wealth
Hashtags

Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
28 minutes ago
- Yahoo
Trump's tariffs and tax bill look like a 'Greek tragedy' that could tank the economy and stocks, former IMF official warns
Trump's economic policies pose the risk of inflation and recession, says former IMF official Desmond Lachman. He is among a chorus of experts that have expressed concern over Trump's proposed tariffs and tax cuts. Rising inflation and bond yields as a result of these policies could hurt stocks, Lachman warns. Like a protagonist in a Greek tragedy, President Donald Trump is exhibiting a concerning level of hubris in his handling of the US economy, former IMF official Desmond Lachman worries. Despite warnings from credible sources — like Fed Chair Jerome Powell, JPMorgan CEO Jamie Dimon, and BlackRock CEO Larry Fink — about what tariffs would mean for inflation and growth, and what his tax cut bill would mean for bond yields and the US dollar, Trump is doubling down on these policies, Lachman said in a June 10 post for the American Enterprise Institute, where he is a senior fellow. Unless Trump changes course, Lachman said, he could end up reigniting inflation, pushing up long-term bond yields, further tanking the US dollar, and sending the US economy into recession. "To Trump, these warnings are like water off a duck's back. Instead of dialing back his tariff policy, Trump has recently raised the import tariff on all aluminum and steel imports to a staggering 50%," Lachman wrote. He continued: "At the same time, instead of coming up with belt-tightening revenue and spending measures to address the country's gaping budget deficit of 6.25% of GDP, Trump is making every effort to secure the passage of his budget-busting One Big Beautiful Bill." So far, inflation has been tame and the labor market has held up as businesses have started to digest tariffs. But Lachman said the US economy is not out of the woods yet. Since businesses stockpiled inventory to prepare for Trump's tariffs, their effects won't start to show up until the second half of the year, he told Business Insider on Friday. "The fact that you're not seeing it in the May, June, July data, it doesn't mean anything," Lachman said. Here's the US trade deficit showing a surge in foreign goods buying from US businesses in late 2024 and early 2025. But tariffs aren't the only inflationary factor potentially at play. Lachman said that if you add the implications of Trump's tax bill on the value of the US dollar as the the national debt and budget deficit grow, consumers could end up paying even higher prices. With the dollar's value down 10%, for example, it means foreign goods are more expensive in addition to the 10% tariffs, or more, already being paid. In an inflationary environment — and with no indication that the US government is looking to reduce its debt and budget deficit — foreign investors have started to flee, and could continue to do so. That could send long-term Treasury rates soaring, Lachman said, slowing the US economy as the cost of lending follows suit. All of this puts US stocks in danger with valuations elevated, Lachman said. For example, here's the Shiller cyclically-adjusted price-to-earnings ratio for the S&P 500, which measures current stock prices against a rolling average of earnings over the last 10 years. "Start with the fact that the stock market has got very high valuations, and then overlay that with the likelihood that you could have either a bond or a dollar crisis, and it would seem to me that stocks don't do very well," he said. The myth probably most associated with hubris and its sometimes disastrous consequences is the tale of Icarus. Looking to escape from a labyrinth, his father builds him wings made of wax. Icarus succeeds in getting off the ground, but in the end ignores his father's warnings and flies too close to the sun, melting his wings. Trump having imposed steep universal tariffs without sparking inflation or a recession has so far defied conventional wisdom and warnings from top economists. But with Trump's tax bill on the way, will his wings, along with the US economy and stock market, soon start to melt? Read the original article on Business Insider Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
Yahoo
38 minutes ago
- Yahoo
1 Energy Stock With a Dividend Yield Over 7% Right Now
MPLX has a much higher dividend yield than the average energy stock. The master limited partnership's payout is on a sustainable foundation. It has been growing its earnings and distribution at healthy rates, and should continue to do so. 10 stocks we like better than MPLX › The energy sector can be a great place for income investors to find higher-yielding options. The average energy stock in the S&P 500 has a yield of around 3% at its current share price, which is more than double the 1.3% yield of the broad market index. Many energy stocks have even higher yields. One of them is MPLX (NYSE: MPLX). The midstream energy company yields more than 7% right now. Here's why income investors will want to take a closer look at MPLX. A yield above 7% might seem like a higher-risk income stream at first glance. However, that's not the case with MPLX's payout. The master limited partnership (MLP) has a rock-solid financial foundation supporting its big-time distribution. MPLX has a diversified midstream operation that generates lots of stable cash flow backed by long-term contracts and government-regulated rate structures. It produced nearly $1.5 billion in distributable cash flow during the first quarter -- enough to cover its distribution by a comfortable 1.5 times. The MLP produced about $500 million in excess free cash flow during the period. That was enough money to cover its organic capital spending with room to spare. (Its net cash used in investing activities was about $364 million after adjusting for acquisitions.) MPLX also has a robust balance sheet. It ended the first quarter with a leverage ratio of 3.3. That's comfortably below the 4.0 or so ratio its stable cash flows can support. MPLX stands out among higher-yielding dividend stocks because it's growing at a healthy clip. Its adjusted earnings before interest, taxes, depreciation, and amortization (EBITDA) rose by 7% in the first quarter. Meanwhile, its distributable cash flow was up 8.5%. The company has been growing its earnings and cash flow at a nearly 7% compound annual rate since 2021. That strong growth, along with the company's top-notch financial profile, has allowed MPLX to increase its distribution at a 10.7% compound annual rate since 2021, including by 12.5% last year. The MLP has plenty more growth coming down the pipeline. It has secured several new investments this year. MPLX and its partners recently made a final investment decision to build the Traverse Pipeline, which should enter commercial service in 2027. It's also building two Gulf Coast fractionators and a liquefied petroleum gas (LPG) export terminal, expanding its BANGL pipeline, building the Blackcomb and Rio Bravo pipelines, and constructing two more natural gas processing plants. These projects have in-service dates through 2029, giving the MLP lots of visibility into its earnings growth. "We continue to anticipate mid-teen returns on these projects, which will support mid-single digit adjusted EBITDA growth," said CEO Maryann Mannen in the first-quarter earnings press release. "This growth is expected to allow us to reinvest in the business and support annual distribution increases in the future." MPLX also continues to use its strong balance sheet to make acquisitions. Early this year, it agreed to buy the 55% of the BANGL pipeline it didn't already own for $715 million, another 5% interest in the Matterhorn Express pipeline for $151 million, and a crude oil gathering system for $237 million. Given its low leverage ratio, it has ample financial flexibility to continue making bolt-on acquisitions as opportunities arise. These and future deals will further enhance its earnings growth rate, giving it more fuel to increase its distribution. MPLX is currently paying over 7%, which is much higher than the average energy stock and the S&P 500. The MLP's big-time payout is on a very sustainable foundation. Further, it should continue growing for the next several years. That makes it a great option for income-seeking investors as long as they are comfortable receiving the Schedule K-1 federal tax form the MLP sends them each year. Before you buy stock in MPLX, consider this: The Motley Fool Stock Advisor analyst team just identified what they believe are the for investors to buy now… and MPLX wasn't one of them. The 10 stocks that made the cut could produce monster returns in the coming years. Consider when Netflix made this list on December 17, 2004... if you invested $1,000 at the time of our recommendation, you'd have $653,702!* Or when Nvidia made this list on April 15, 2005... if you invested $1,000 at the time of our recommendation, you'd have $870,207!* Now, it's worth noting Stock Advisor's total average return is 988% — a market-crushing outperformance compared to 172% for the S&P 500. Don't miss out on the latest top 10 list, available when you join . See the 10 stocks » *Stock Advisor returns as of June 9, 2025 Matt DiLallo has no position in any of the stocks mentioned. The Motley Fool has no position in any of the stocks mentioned. The Motley Fool has a disclosure policy. 1 Energy Stock With a Dividend Yield Over 7% Right Now was originally published by The Motley Fool
Yahoo
an hour ago
- Yahoo
HC Wainwright Starts Travere Therapeutics, Inc. (TVTX) at Buy on FILSPARI Breakthroughs
Travere Therapeutics, Inc. (NASDAQ:TVTX) is among the 10 Best Growth Stocks Under $100 to Buy Now. HC Wainwright & Co., a leading investment bank, has initiated a 'Buy' rating for Travere Therapeutics, Inc. (NASDAQ:TVTX), with a price target of $30, signaling an upside of around 100%. This confidence in the company underscores its position in the pharmaceutical sector. The company has just announced plans to present three new abstracts underscoring the impact of FILSPARI (sparsentan) in rare kidney disease at the International Podocyte Conference, taking place in Hamburg, Germany. The findings of FILSPARI, showcasing advanced reductions in urinary BAFF and sC5b9, along with dips in the proinflammatory and profibrotic biomarkers, signal a step forward in the treatment of IgAN. A laboratory technician working on a solution of rare diseases, housed in a cholic acid capsule. With net sales of FILSPARI increasing 182% year-over-year and the successful approval of FILSPARI in Europe and the UK, analysts have little doubt about the company's potential. Since the major revenue contribution comes from FILSPARI, the rising popularity and increasing adoption among nephrologists mean that Travere Therapeutics, Inc. (NASDAQ:TVTX) can continue to leverage a product that is quite differentiated. Travere Therapeutics, Inc. (NASDAQ:TVTX) is a biopharmaceutical company incorporated in 2008. This California-based giant recognizes, develops, and commercializes therapies for people suffering from rare kidney and metabolic diseases in the United States. While we acknowledge the potential of TVTX as an investment, we believe certain AI stocks offer greater upside potential and carry less downside risk. If you're looking for an extremely undervalued AI stock that also stands to benefit significantly from Trump-era tariffs and the onshoring trend, see our free report on the best short-term AI stock. READ NEXT: The Best and Worst Dow Stocks for the Next 12 Months and 10 Unstoppable Stocks That Could Double Your Money. Disclosure: None. Sign in to access your portfolio